Cytoreason Private Financing
LOCUST WALK NEWS CytoReason secures $80M from OurCrowd, NVIDIA, Pfizer, and Thermo Fisher Scientific to scale its AI disease models […]
LOCUST WALK NEWS CytoReason secures $80M from OurCrowd, NVIDIA, Pfizer, and Thermo Fisher Scientific to scale its AI disease models […]
LOCUST WALK NEWS Locust Walk Acquisition Corp. Announces Pricing of Upsized $153,000,000 Initial Public Offering PHILADELPHIA and BOSTON, Jan. 7,
LOCUST WALK NEWS Ascentage Pharma Signs Option Agreement with Takeda to Enter into Exclusive Global License for Olverembatinib Ascentage Pharma
Align Summit 2024 Align Summit – April 25, 2024 Locust Walk proudly partnered with MassBio and McKinsey & Co. for
Loucst Walk RNA Innovation Conference in partnership with Dr. Frank Slack, Director of the Harvard Medical School Initiative for RNA
Locust Walk Stem Cell Tx Conference in partnership with Harvard Stem Cell Institute April 11th, 2022, Conference in Review We
Podcast: Play in new window | Download (Duration: 33:54 — 77.6MB)
Subscribe: Apple Podcasts | Spotify | RSS
On this episode of Biotalk, Locust Walk’s Geoff Meyerson welcomes Stephen Sands, former Vice Chairman of Investment Banking and Chairman of the Global
Transaction Case Studies MULTI-TRACK ENGAGEMENT LEADING TO AN EQUITY INVESTMENT Situation Assessment Rapid Micro Biosystems is a privately held, commercial
Transaction Case Studies GLOBAL DEAL WITH A JAPANESE COMPANY FOR BRINCIDOFOVIR, A BROAD-SPECTRUM ANTIVIRAL FOR THE TREATMENT AND PREVENTION OF
Transaction Case Studies RAPID M&A ADVISORY Situation Assessment Anokion Bio is Swiss biotechnology company focused on autoimmune diseases by restoring